Welcome to the TRANSEURO consortium website
01

TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for Parkinson’s disease suffering patients using fetal cell based treatments. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson's Disease.

TRANSEURO is coordinated by Prof. Roger Barker from the Cambridge University and is funded by the 7th Framework Program of the European Commission, Contract number HEALTH-F5-2010-242003.

 

Latest news
     
Press release, November 30, 2012 Transplant of brain cells for Parkinson's patients In early 2013 | more... |   "Ny metod ska hejda parkinson" - The Transeuro project described in Swedish newspaper SYDSVENSKAN | more... |
 
Press release, November 27, 2012 (Swedish) Transplantation av hjärnceller i början på 2013 | more... |  

"Mitt liv är ju här och nu" - The Transeuro project described in Swedish newspaper SYDSVENSKAN | more... |

 
"Nytt hopp för parkinsonpatienter" short commentary about the Transeuro consortium aired during evening news in Sweden on November 27, 2012 | more... |    

 

     
Upcoming Events
 

TRANSEURO Consortium thematic workshop "Cells for patients: meeting the GMP challenge"
September 2nd-3rd 2013, Cardiff, UK

- more information about the workshop and registration can be found here
- tentative agenda of the workshop can be downloaded here

 
 
 
 

 

FP7 You are Number_of_visits visitor of our webpage EU flag
  Last update: May 2013  

 

 

Home disease objectives contact intranet